Your browser doesn't support javascript.
loading
The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Emmerson, Paul J; Wang, Feng; Du, Yong; Liu, Qian; Pickard, Richard T; Gonciarz, Malgorzata D; Coskun, Tamer; Hamang, Matthew J; Sindelar, Dana K; Ballman, Kimberly K; Foltz, Lisa A; Muppidi, Avinash; Alsina-Fernandez, Jorge; Barnard, Gavin C; Tang, Jason X; Liu, Xilin; Mao, Xudong; Siegel, Robert; Sloan, John H; Mitchell, Pamela J; Zhang, Bei B; Gimeno, Ruth E; Shan, Bei; Wu, Xinle.
Afiliación
  • Emmerson PJ; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Wang F; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Du Y; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Liu Q; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Pickard RT; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Gonciarz MD; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Coskun T; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Hamang MJ; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Sindelar DK; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Ballman KK; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Foltz LA; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Muppidi A; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Alsina-Fernandez J; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Barnard GC; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Tang JX; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Liu X; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Mao X; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Siegel R; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Sloan JH; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Mitchell PJ; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Zhang BB; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Gimeno RE; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly &Company, Indianapolis, Indiana, USA.
  • Shan B; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
  • Wu X; Lilly China Research and Development Center (LCRDC), Eli Lilly &Company, Shanghai, China.
Nat Med ; 23(10): 1215-1219, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28846098

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Área Postrema / Ingestión de Alimentos / Receptores del Factor Neurotrófico Derivado de la Línea Celular Glial / Factor 15 de Diferenciación de Crecimiento / Obesidad Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Área Postrema / Ingestión de Alimentos / Receptores del Factor Neurotrófico Derivado de la Línea Celular Glial / Factor 15 de Diferenciación de Crecimiento / Obesidad Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2017 Tipo del documento: Article